Latest News about Analyst Ratings
Recent news which mentions Analyst Ratings
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
April 01, 2025
From Benzinga
Analyst Expectations For Gaming and Leisure Props's Future
April 01, 2025
Tickers
GLPI
From Benzinga
Demystifying Spire Global: Insights From 8 Analyst Reviews
April 01, 2025
Tickers
SPIR
From Benzinga
Tariffs Could Shake Building Industry: Homebuilders, Plumbing, Flooring Face Rising Costs
April 01, 2025
From Benzinga
Knight-Swift Faces Pressure With Lack Of Freight Flows Amid Tariffs, Analyst Downgrades Stock
April 01, 2025
From Benzinga
From Benzinga
Spotify Audiobooks, Ad Growth Drive Analyst Confidence
April 01, 2025
From Benzinga
From Benzinga
TechTarget Faces Macro Challenges And Valuation Compression, Analyst Cuts Price Forecast
April 01, 2025
Tickers
TTGT
From Benzinga
Goldman Sachs Shakes Up Auto Parts Stocks: Downgrades Genuine Parts, Upgrades AutoZone Amid Economic Volatility
April 01, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.